Vogt A - Search Results

1

Single lipoprotein apheresis session improves cardiac microvascular function in patients with elevated lipoprotein(a): detection by stress/rest perfusion magnetic resonance imaging.

Bohl S, Kassner U, Eckardt R, Utz W, Mueller-Nordhorn J, Busjahn A, Thomas HP, Abdel-Aty H, Klingel R, Marcovina S, Dietz R, Steinhagen-Thiessen E, Schulz-Menger J, Vogt A. Bohl S, et al. Among authors: vogt a. Ther Apher Dial. 2009 Apr;13(2):129-37. doi: 10.1111/j.1744-9987.2009.00667.x. Ther Apher Dial. 2009. PMID: 19379152 Clinical Trial.

2

Autosomal recessive hypercholesterolemia in three sisters with phenotypic homozygous familial hypercholesterolemia: diagnostic and therapeutic procedures.

Thomas HP, Vogt A, Wilund KR, Schliesser C, Steinhagen-Thiessen E, Kassner U. Thomas HP, et al. Among authors: vogt a. Ther Apher Dial. 2004 Aug;8(4):275-80. doi: 10.1111/j.1526-0968.2004.00143.x. Ther Apher Dial. 2004. PMID: 15274677

3

Does regular lipid apheresis in patients with isolated elevated lipoprotein(a) levels reduce the incidence of cardiovascular events?

Rosada A, Kassner U, Vogt A, Willhauck M, Parhofer K, Steinhagen-Thiessen E. Rosada A, et al. Among authors: vogt a. Artif Organs. 2014 Feb;38(2):135-41. doi: 10.1111/aor.12135. Epub 2013 Jul 25. Artif Organs. 2014. PMID: 23889507

4

Quality of life in patients treated with lipoprotein apheresis.

Rosada A, Kassner U, Banisch D, Bender A, Steinhagen-Thiessen E, Vogt A. Rosada A, et al. Among authors: vogt a. J Clin Lipidol. 2016 Mar-Apr;10(2):323-9.e6. doi: 10.1016/j.jacl.2015.12.009. Epub 2015 Dec 22. J Clin Lipidol. 2016. PMID: 27055963

5

Designing a study to evaluate the effect of apheresis in patients with elevated lipoprotein(a).

Kassner U, Vogt A, Rosada A, Barz F, Giannakidou-Jordan E, Berthold HK, Steinhagen-Thiessen E. Kassner U, et al. Among authors: vogt a. Atheroscler Suppl. 2009 Dec 29;10(5):85-8. doi: 10.1016/S1567-5688(09)71818-5. Atheroscler Suppl. 2009. PMID: 20129382

6

Correction of low HDL cholesterol to reduce cardiovascular risk: practical considerations relating to the therapeutic use of prolonged-release nicotinic acid (Niaspan).

Vogt A, Kassner U, Hostalek U, Steinhagen-Thiessen E. Vogt A, et al. Int J Clin Pract. 2007 Nov;61(11):1914-21. doi: 10.1111/j.1742-1241.2007.01514.x. Int J Clin Pract. 2007. PMID: 17935550 Review.

7

Prolonged-release nicotinic acid for the management of dyslipidemia: an update including results from the NAUTILUS study.

Vogt A, Kassner U, Hostalek U, Steinhagen-Thiessen E. Vogt A, et al. Vasc Health Risk Manag. 2007;3(4):467-79. doi: 10.2147/vhrm.s1023. Vasc Health Risk Manag. 2007. PMID: 17969377 Free PMC article. Review.

8

[Safety and tolerability of nicotinic acid. Results of the multicenter, open, prospective NAUTILUS study].

Vogt A, Kassner U, Hostalek U, Peiter A, Steinhagen-Thiessen E. Vogt A, et al. MMW Fortschr Med. 2006 May 4;148(18):41. MMW Fortschr Med. 2006. PMID: 16736688 German. No abstract available.

9

[Lipid reduction without medication. What effect does diet have on lipids?].

Vogt A, Steinhagen-Thiessen E. Vogt A, et al. Pharm Unserer Zeit. 2003;32(6):452-7. doi: 10.1002/pauz.200300043. Pharm Unserer Zeit. 2003. PMID: 14639825 Review. German. No abstract available.

10

[Primary and secondary prevention in dyslipidemia in the elderly].

Vogt A, Nieczaj R, Thomas HP, Borchelt M, Steinhagen-Thiessen E. Vogt A, et al. Ther Umsch. 2002 Jul;59(7):341-4. doi: 10.1024/0040-5930.59.7.341. Ther Umsch. 2002. PMID: 12185949 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,055 results

Search Page

Filters